Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perhexiline for myocardial protection in left ventricular hypertrophy during aortic valve surgery
2008-002376-95Phase 3Terminated
- Sponsor
- University Hospitals Birmingham
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of piroxicam-beta-cyclodextrin in left ventricular hypertrophy (LVH) (2 arms), sponsored by University Hospitals Birmingham. Primary endpoint: Incidence of low cardiac output syndrome after surgery. Started Nov 2008; status: terminated.
02
Drugs
piroxicam-beta-cyclodextrin
03
Conditions
left ventricular hypertrophy (LVH)
Beyond the preview
Go deeper on 2008-002376-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002376-95.